Skip to contentKlassen Preston — Orexigen Therapeutics, Inc. insider: 76 transactions · InsiderLensKlassen Preston
- President & Head of R & D at Regulus Therapeutics Inc. · on record since Jun 12, 2023
- Director at Regulus Therapeutics Inc. · on record since Aug 14, 2023
- Director at Conatus Pharmaceuticals Inc · on record since Feb 11, 2014
- EVP, Global Development at Orexigen Therapeutics, Inc. · on record since Feb 4, 2016
- EVP and CMO at ARENA PHARMACEUTICALS INC · on record since Mar 20, 2017
- Director at Metacrine, Inc. · on record since Sep 15, 2020
- President & CEO at Metacrine, Inc. · on record since Sep 15, 2020
- President and COO at Zura Bio Ltd · on record since Mar 21, 2023
Insider trading activity of Klassen Preston
- Transactions on record
- 76
- since Sep 22, 2010
- Open-market buys
- 2
- $170.7K
- Open-market sells
- 9
- $1.7M
- Companies traded
- 5
- last filing Jun 27, 2025
Figures computed from official regulatory filings — methodology.
Companies where Klassen Preston has traded
Track record of Klassen Preston
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of Klassen Preston
Co-insiders of Klassen Preston
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Chang CarmenMetacrine, Inc. +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 27, 2025 | OtherD | -350,000 | — | — | SEC |
| Jun 27, 2025 | Other | -115,555 | — | — | SEC |
| Jun 27, 2025 | OtherD | -120,000 | — | — | SEC |
| Jun 27, 2025 | OtherD | -225,000 | — | — | SEC |
| Jun 27, 2025 | OtherD | -675,000 | — | — | SEC |
| Jun 27, 2025 | OtherD | -528,000 | — | — | SEC |
| Jun 4, 2025 | Buy | 12,000 | 7.99 USD | $95.9K | SEC |
| Jan 31, 2025 | AwardD | 675,000 | 0.00 USD | $0 | SEC |
| Jan 15, 2025 | Sell | -31,445 | 1.26 USD | $39.6K | SEC |
| Jan 10, 2025 | Award | 30,000 | 1.30 USD | $39K | SEC |
| Jan 10, 2025 | Award | 37,500 | 1.36 USD | $51K | SEC |
| May 21, 2024 | AwardD | 528,000 | 0.00 USD | $0 | SEC |
| Jan 17, 2024 | AwardD | 120,000 | 0.00 USD | $0 | SEC |
| Aug 14, 2023 | AwardD | 225,000 | 0.00 USD | $0 | SEC |
| Jun 12, 2023 | AwardD | 350,000 | 0.00 USD | $0 | SEC |
| Mar 24, 2023 | OtherD | -842,211 | 0.00 USD | $0 | SEC |
| Mar 24, 2023 | Award | -842,211 | 0.47 USD | $395.8K | SEC |
| Jan 27, 2023 | Sell | -380,605 | 0.41 USD | $156K | SEC |
| Apr 20, 2022 | Sell | -1,173 | 0.51 USD | $598.2 | SEC |
| Apr 20, 2022 | Sell | -43,575 | 0.50 USD | $21.8K | SEC |
| Apr 18, 2022 | Award | 104,500 | 0.00 USD | $0 | SEC |
| Mar 1, 2022 | AwardD | 842,211 | 0.00 USD | $0 | SEC |
| Mar 1, 2022 | Award | 842,211 | 0.00 USD | $0 | SEC |
| May 20, 2021 | Buy | 20,547 | 3.64 USD | $74.8K | SEC |
| Feb 12, 2021 | AwardD | 247,500 | 0.00 USD | $0 | SEC |